Oral Upadacitinib Beats Subcutaneous Dupilumab for Atopic Dermatitis. Slomski A. JAMA 2021;326:1246.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Slomski A. Oral Upadacitinib Beats Subcutaneous Dupilumab for Atopic Dermatitis. JAMA 2021;326:1246.
PMID: 34609462